The pace of forming academic spin-out companies picked up in the US in 2004 after a two-year slump, according to a survey released today.

Britain's privatised defence lab ties up with 7 universities, in a strategy to do more with fewer partners.

After the initial hype, the long haul through clinical development and the inevitable pitfalls, gene therapy is on the verge of becoming a commercial reality in Europe - ahead of the US.

Nuala Moran takes a behind-the-scenes look at the strategies involved in Europe's biggest patent victory in years.

Jo Taylor, head of venture capital at 3i Group, argues that universities are too quick to hit the spin-out button.

A spin-out from Sheffield that uses stem cells to help with conventional drug discovery is looking for investment to continue pre-clinical research on therapeutic applications and business development activities.

When Google hired Kai-fu Lee from Microsoft to set up the internet company's new R&D centre in Beijing in July, it set off a legal battle that highlights how much is at stake in the rush to cash in on the country's booming economy and vast scientific labour force.

A Karolinska team is using microarrays for adjuvant therapy – and is looking for partners

A microchip that mimics the function of the human brain could one day result in a mobile phone with the memory capacity of a desktop computer, researchers report.

Despite the naysayers, more and more women are gaining success in the business of science. Our global investigation shows what it takes: good education, determination, a good employer, and some luck. Memo to government – Help them out.